Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

FSD Pharma Now Licensed to Sell to other LPs

Stockhouse Editorial
0 Comments| November 13, 2018

{{labelSign}}  Favorites
{{errorMessage}}

FSD Pharma Inc.(CSE: HUGE, OTCQB: FSDDF, Forum) stated on Tuesday that it has received a license to sell to other licensed producers through its wholly-owned subsidiary, FV Pharma Inc. under the Access to Cannabis for Medical Purposes Regulations. The Company is also expanding its growth production footprint.

For more on this, click here.

FSD was in the news recentlywhen it announced that that its partner, SciCann Therapeutics Inc., received a positive International Search Authority report from the Patent Cooperation Treaty for its SCN-001 cannabidiol combination therapy patent, the basis of FSD’s “Steady Stomach” product.


FULL DISCLOSURE: FSD Pharma Inc. is a paid client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today